ReachMD

NeuroFrontiers

Science EN ↓ 184 episodes

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health. So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

Author

ReachMD

Category

Science

Podcast website

reachmd.com

Latest episode

Jun 24, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Exploring New Research on Melanoma Brain Metastases 28.09.2022

Guest: Benjamin Izar, MD Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Brain metastases are common in patients with advanced melanoma and are a leading cause of cancer-related death. However, little is known as to why melanoma spreads to the brain, but new research from Columbia University may provide some answers. To discuss this recent di...

Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia 30.08.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Jason Barton, MD, PhD, FRCP(C) Prosopagnosia, also known as face blindness, is a rare cognitive disorder. Joining Dr. Andrew Wilner to share his insights on this condition is Dr. Jason Barton, a Professor of Neurology, Ophthalmology and Visual Sciences, and Psychology at the University of...

Advances in Temporal Lobe Epilepsy Research 29.08.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Sanjay Kumar, PhD Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy. Due to recent research from Florida State University, we might have a better understanding of the potential link between a specific protein and increased vulnerability to neurodegeneration among pati...

AI in Neurology: What Tools Are Emerging? 30.06.2022

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Mark Mintz, MD Recent developments in artificial intelligence (AI) technology have shown to aid with neurological disease diagnosis, risk stratification, treatment response, and more. So what are the newest AI applications? And perhaps even more importantly, what’s to come in the future? To find out the answer to these and other key questions, Dr. Jero...

Clinical Considerations for the Treatment of Schizophrenia 07.06.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Craig Chepke, MD, FAPA Schizophrenia is a chronic mental disorder characterized by symptoms that negatively affect a patient’s mental and emotional behaviors. And although there are current treatment options including first and second-generation antipsychotics, treatment challenges still...

Investigating the Link Between Hypertension Medications & Dementia 23.05.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Zachary Marcum, PharmD, PhD Hypertension affects nearly half of adults in the United States and is associated with cognitive decline and dementia. A wide variety of antihypertensive medications are prescribed to millions of people to control blood pressure and prevent vascular dementia. C...

B-Cell Therapy: When Is It Right for Our MS Patients? 19.05.2022

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Chan, MD Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple sclerosis (MS), but their exact role is unclear. Despite that uncertainty, B-cell depletion therapies have shown to ease symptoms, prevent relapses, and even slow the course of the disease. So how exactly do B-cell therapies work, and how do we kn...

Alzheimer’s Disease: What’s The Latest Research? 26.04.2022

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Peter Whitehouse, MD, PhD Guest: Daniel George, MSc, PhD Although there’s still no cure for Alzheimer’s disease, we’ve made great strides in understanding the tragic disease that affects more than 50 million people worldwide. So what are the latest updates in treating and alleviating this disease? To learn more about what’s new in Alzheimer’s disease r...

Diving into the Debate Surrounding Aducanumab for Alzheimer’s 20.04.2022

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Peter Whitehouse, MD, PhD The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversial response. So what do we need to know about this new drug and its potential to treat this progressive neurological disorder? Dr. Jerome Lisk is joined by Dr. Peter Whitehouse from Case Western Reserve University to...

Keys to Closing the Gender Gap in Stroke Trials 14.03.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Cheryl Carcel, MD, PhD Although research suggests that women have a similar stroke risk as men, a new analysis has found that a very small percentage of participants in clinical trials investigating stroke treatments are female. So why are women underrepresented in these clinical trials,...

Diagnosing Mental Illness with the Perspectives Approach 18.02.2022

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Margaret Chisolm, MD The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook traditionally used by healthcare professionals to guide the diagnosis of psychiatric conditions, but a number of psychiatrists advocate for the perspectives approach, which extends beyond the DSM model. So how exactly do these two models differ? And h...

Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics 07.01.2022

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Jose Rubio, MD Schizophrenia is rarely a single-episode illness. In fact, 8 out of 10 patients will experience a relapse of symptoms after initial treatment. So how can we help reduce the frequency of relapse—and even non-adherence—among our patients with schizophrenia? To find out, Dr. A...

Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients 27.12.2021

Host: Jennifer Caudle, DO Guest: Vikram V. Bhise, MD Pediatric multiple sclerosis (MS) occurs in more than 8,000 children in the United States alone, but there’s little data regarding these patients’ quality of life. That’s why Dr. Vikram Bhise recently conducted research to gain a better understanding of pediatric MS patients’ quality of life as they transition into adulthood. And now, Dr. Bhise...

The Importance of Collaboration in MS Care: Takeaways from CMSC 16.12.2021

Guest: Patty Bobryk, MHS, PT, MSCS, ATP A multidisciplinary approach to multiple sclerosis (MS) is becoming more and more integral in practice as research continues to emerge on its significance. That’s why physical therapist Ms. Patty Bobryk is here to debrief us on some highlights from the rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) that focused on collaborat...

A Recap of the Rehabilitation Track at CMSC 16.12.2021

Guest: Patty Bobryk, MHS, PT, MSCS, ATP The rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) was filled with key updates regarding collaboration, nonpharmaceutical symptom management strategies, and more. And Ms. Patty Bobryk, a physical therapist at Yampa Valley Medical Center, is here to review those updates with us.

What to Know About Post-COVID-19 Neurological Syndrome 07.12.2021

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Tissa Wijeratne MD PhD FRACP FRCP FAAN Since the onset of the COVID-19 pandemic, researchers and clinicians alike have strived to address the mysteries surrounding the virus, including its long-term side effects on patients. So what we do need to know about the emerging syndrome pointing to COVID-19’s neurological and cognitive impacts? To find out, Dr...

Could T Cells Lead to New MS Treatments? 26.10.2021

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Shivashankar Othy, DVM, PhD Despite the high prevalence of multiple sclerosis (MS), there’s still a lot we don’t know about this disease. One such area of uncertainty is in regard to how MS causes the immune system to become dysfunctional, but this knowledge is key as it could help us develop new treatment options. And now, we might be one step closer...

Caring for Treatment-Resistant Schizophrenia: Is DBS the Answer? 01.10.2021

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Nicola Cascella, MD Although there’s currently no cure for schizophrenia, it can be managed with therapy and medication—for some patients, that is. In fact, up to one-half of patients with severe symptoms don’t respond to medication. So how are we to care for this large percentage of pati...

What to Consider When Treating Transgender Patients with Epilepsy 10.09.2021

Host: Andrew Wilner, MD, FACP, FAAN Guest: Emily Louise Johnson, MD According to recent estimates, between 150,000 and 450,000 transgender patients have epilepsy. And as that number is only expected to grow, Assistant Professor of Neurology at Johns Hopkins School of Medicine Dr. Emily Johnson shares key considerations for treating transgender patients with epilepsy.

Women & Mental Health: Taking a Targeted Treatment Approach 14.06.2021

Guest: Maheen Mausoof Adamson, PhD Tune in to hear Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, discuss her study on mental health in women and how we can take a more targeted treatment approach.

Uncovering Unknowns in TBI: An Exploration of Manifestations in Women 10.06.2021

Host: Andrew Wilner, MD, FACP, FAAN Guest: Maheen Mausoof Adamson, PhD Traumatic brain injury, or TBI, manifests differently in men and women. Here to explore these differences is Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, meets with Dr. Andrew Wilner to discuss traumatic brain injuries in female patients.

Real-Time Dialogue with Dreamers: An Exploration of Communication During REM Sleep 13.05.2021

Host: Andrew Wilner, MD, FACP, FAAN Guest: Ken Paller, PhD Lucid dreaming is complex and remains a mystery to many neurologists, but emerging research suggests we may be able to communicate with dreamers in REM sleep. Dr. Andrew Wilner is joined by Dr. Ken Paller, Northwestern University's Director of the Cognitive Neuroscience program and the training program in the Neuroscience of Human Cognitio...

Understanding the Brain: An Exploration of an Extraordinary Organ 13.05.2021

Host: Andrew Wilner, MD, FACP, FAAN Guest: Bret Stetka, MD What do we know about the progression of the human brain? Dr. Andrew Wilner meets with Science Journalist Dr. Bret Stetka to discuss his new book, “A History of the Human Brain: From the Sea Sponge to CRISPR, How Our Brain Evolved.”

The Dangers of a Broken Heart: Collaborating on Cardiomyopathy 01.04.2021

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Ilan Wittstein, MD How do you mend a broken heart? Dr. Ilan Wittstein, the Director of the Advanced Heart Failure Fellowship and Assistant Professor of Medicine at Johns Hopkins School of Medicine, joins Dr. Jerome Lisk to discuss broken heart syndrome and some of its challenges.

Deep Brain Stimulation in the OR: What Neurologists & Patients Can Expect 31.03.2021

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Jerrold Vitek, MD, PhD Deep brain stimulation, or DBS, is an emerging surgical procedure that may help to manage movement disorders such as Parkinson’s disease. Dr. Jerrold Vitek joins Dr. Jerome Lisk to share what is to be expected when a patient undergoes this type of procedure.

Listen to the NeuroFrontiers podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.